Renal Denervation Round 2: Medtronic, Boston Sci Move Ahead With Studies

Medtronic and Boston Scientific are getting set to launch new trials of their renal denervation technologies, both believing they can overcome the problems that caused Medtronic's SYMPLICITY HTN-3 sham-controlled trial to miss its primary endpoint last year.